Avastin and Tenormin drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among 60 people who take Avastin and Tenormin. Common interactions include ear haemorrhage among females, and death among males.
The phase IV clinical study analyzes what interactions people who take Avastin and Tenormin have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
60 people who take Avastin and Tenormin together, and have interactions are studied.
What is Avastin?
Avastin has active ingredients of bevacizumab. It is used in high blood cholesterol. Currently, eHealthMe is studying from 73,730 Avastin users.
What is Tenormin?
Tenormin has active ingredients of atenolol. It is used in high blood pressure. Currently, eHealthMe is studying from 20,306 Tenormin users.
Number of Avastin and Tenormin reports submitted per year:
Common Avastin and Tenormin drug interactions by gender *:
- Ear haemorrhage
- Eye disorder
- Eye haemorrhage
- Eye pain
- Heart rate irregular
- Kidney infection
- Myocardial infarction
- Renal colic
- Gastric ulcer
- Renal disorder
Common Avastin and Tenormin drug interactions by age *:
- Renal failure
- Abdominal pain upper
- Chronic kidney disease
- Hyperparathyroidism secondary
- Nephrogenic anaemia
- Myocardial infarction
- Balance disorder
- Bladder cancer
- Bladder disorder
- Cardiac disorder
- Cerebral atrophy
- Cerebrovascular accident
- Ear haemorrhage
Common conditions people have *:
- Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 7 people, 11.67%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 6 people, 10.00%
- Breast Cancer Metastatic: 5 people, 8.33%
- Lung Adenocarcinoma (a form of non-small cell lung cancer): 4 people, 6.67%
- Colon Cancer: 4 people, 6.67%
- Vitreous Haemorrhage (intraocular (inside the eye) bleeding): 3 people, 5.00%
- Gastroenteritis (inflammation of stomach and intestine): 3 people, 5.00%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 5.00%
- Cerebral Infarction (less blood supply to brain resulting tissue damage): 3 people, 5.00%
- Diabetes: 3 people, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Avastin and Tenormin?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drug side effects by duration, gender and age:
Common Avastin drug interactions:
Browse interactions between Avastin and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Tenormin drug interactions:
Browse interactions between Tenormin and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on bevacizumab and atenolol (the active ingredients of Avastin and Tenormin, respectively), and Avastin and Tenormin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Avastin and Tenormin.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Doxorubicin Hydrochloride and Zanaflex drug interaction - now
- Diphenhydramine Hydrochloride and Endometrial Disorder - 2 seconds ago
- Effexor and Eschar - 6 seconds ago
- Doxorubicin Hydrochloride and Pain Exacerbated - 10 seconds ago
- Sirolimus and Hydramine drug interaction - 14 seconds ago
- Darifenacin and Weight Increased - 19 seconds ago
- Femara and Cheilitis - 25 seconds ago
- Polymyxin B Sulfate and Methotrexate drug interaction - 27 seconds ago
- Docetaxel and Tumor Marker Increased - 27 seconds ago
- Dexlansoprazole and Gastroesophageal Reflux Disease - 35 seconds ago